Jul 2026· Cancer Epidemiology· Vol 104, pp.
103194
· 0 citations· 60 references
Medicine
TL;DR
Despite the declines in infection-related cancers, indicative of effective public health interventions, the overall cancer burden is projected to increase through 2040, mainly driven by increasing incidence and mortality of colorectal and breast cancers.
Abstract
Background
Cancer remains a significant public health concern in Thailand, with substantial regional variation. This study quantified long-term temporal trends and projected future burdens of major cancers in Thailand's upper central region, in the context of evolving public health policies and changing epidemiological patterns.
Methods
Population-based cancer data from 2000 to 2022 were obtained from the Lopburi Cancer Hospital. Temporal trends were analyzed using joinpoint regression and the age-period-cohort model. Future burdens were projected to 2040 using joinpoint regression, the age-period-cohort model, and the NordPred model.
Results
Infection-related cancers declined while lifestyle-associated cancers increased. Age-standardized incidence rates (ASIRs) and mortality rates (ASMRs) for liver and lung cancers declined among men. The colorectal cancer burden among men increased markedly, with ASIRs rising from 8.92 to 24.62 per 100,000 person-years (average annual percent change [AAPC] +4.72%, 95% confidence interval [CI], 3.46-6.47), and ASMRs increasing from 1.83 to 12.15 (AAPC +8.97%, 95% CI, 5.70-12.37). Among women, breast cancer incidence increased from 18.48 to 31.46 (AAPC +2.44%, 95% CI, 0.79-4.73), while mortality increased from 2.10 to 10.00 (AAPC +7.35%, 95% CI, 3.86-11.70). Cervical cancer declined in both incidence and mortality. Colorectal cancer incidence among women increased from 6.51 to 12.06 (AAPC +2.84%, 95% CI, 0.89-6.32), with rising mortality (AAPC +4.03%, 95% CI, 2.76-5.95).
Conclusions
Despite the declines in infection-related cancers, indicative of effective public health interventions, the overall cancer burden is projected to increase through 2040, mainly driven by increasing incidence and mortality of colorectal and breast cancers. This highlights the priority need for organized population-based screening programs and targeted interventions addressing modifiable lifestyle and dietary risk factors.
Background
Over the past decades, cancer mortality has declined in many high-income countries owing to reductions in exposure to tobacco and other risk factors, screening programs, and advances in diagnosis and treatment. However, ongoing changes in environmental, behavioral, and metabolic risk factors continue to res...
Nicolò Lentini, C. Santucci, C. la Vecchia et al.· Epidemiology Biostatistics a...· 0 citations
Laryngeal cancer remains a significant global health challenge, with notable disparities across regions, socioeconomic strata, age groups, and genders. Using Global Burden of Disease data (1990-2021), we evaluated prevalence, incidence, mortality, and disability-adjusted life years across 204 countries and 21 regions s...
Jing Liu, Wei Zhu, Yong-Cu Sun et al.· American Journal of Otolaryn...· 0 citations
BACKGROUND
Ovarian cancer remains a major cause of cancer mortality, but contemporary nationwide evidence from Spain is limited.
METHODS
We conducted an ecological time-trend study of ovarian cancer incidence and mortality in Spain (1999-2023). Mortality counts came from the Spanish National Statistics Institute (INE...
L. Cayuela, Maria Llueca, M. Climent et al.· European Journal of Obstetri...· 0 citations
Simple Summary Six major cancers (female breast, colorectal, liver, lung, pancreas, and prostate) substantially impact public health in the U.S. because together they account for a large portion of cancer burden. Monitoring incidence trends can help inform effective prevention strategies. While lung and colorectal canc...
Itunu O. Sokale, Omar Rosales, H. El-Serag et al.· Cancers· 0 citations
Relevance: Lung and gastric cancers remain major contributors to cancer burden in Kazakhstan. Long-term analysis of incidence
and stage at diagnosis can guide cancer-control planning.
The study aimed to characterize trends in lung and gastric cancer incidence and stage distribution and forecast trends through
2035....
Z. Burkitbayev, A. Manatova, S. Shalekenov et al.· Eurasian Journal of Oncology...· 0 citations
Despite declining overall CRC mortality, recent increases were observed in several metastatic and noncancer contributing conditions, and model-based projections indicate that overall lung metastasis mortality will continue to increase through 2040, whereas liver metastasis mortality will peak in 2028 and subsequently d...
Zi-Chen He, Ya-Dong Chen, Yu-Xing Hu et al.· Frontiers in Public Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.